EDGAR Filing Documents for 0001193125-18-217946

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-18-217946

Filing Date

2018-07-13

Accepted

2018-07-13 17:11:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d325115d424b5.htm	424B5	430733
2	GRAPHIC	g325115covlogo_new.jpg	GRAPHIC	5142
3	GRAPHIC	g325115dsp1.jpg	GRAPHIC	3613
4	GRAPHIC	g325115dsp10a.jpg	GRAPHIC	15835
5	GRAPHIC	g325115dsp9a.jpg	GRAPHIC	9780
6	GRAPHIC	g325115dsp9b.jpg	GRAPHIC	11169
7	GRAPHIC	g325115g05f73.jpg	GRAPHIC	110948
	Complete submission text file	0001193125-18-217946.txt		648007

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214418 | Film No.: 18953104
SIC: 2834 Pharmaceutical Preparations